Personalized briefing
Discovery of the day · Clinical Medicine
Digital self-management programme for pain, fatigue and faecal incontinence in inflammatory bowel disease: cost-effectiveness analysis of the IBD-BOOST randomised controlled trial
Dear Ibtihal Talal Balubaid, this is your personalized scientific intelligence briefing — curated for your work in Clinical Medicine.
Key finding
Medicine · Gastroenterology & Health Economics
Discovery of the day
A cost-effectiveness analysis of the IBD-BOOST digital self-management programme demonstrates that this facilitator-supported intervention is highly likely to be cost-effective for managing persistent pain, fatigue, and faecal incontinence in individuals with inflammatory bowel disease. The trial, randomising 391 participants to the intervention and 389 to usual care, found that IBD-BOOST generated an additional 0.016 quality-adjusted life years (QALYs) per participant over 12 months while yielding healthcare cost savings of approximately £305 per participant. For a medical student focused on evidence-based practice and patient outcomes, this study provides compelling economic evidence that a scalable digital intervention can improve quality of life and reduce healthcare utilisation for common, treatment-resistant IBD symptoms — directly informing clinical decision-making and resource allocation in gastroenterology care.
Novelty
72%
Rigor
88%
Significance
78%
Validity
85%
Clarity
90%
Advertisement
ScientificChina — verified Chinese lab & medical equipment suppliers, direct. Browse suppliers →
Your briefing is personalized based on your selected fields, keywords, and research interests.
